dactinomycin has been researched along with tanespimycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhalla, K; Blagosklonny, MV; Broude, EV; Demidenko, ZN; Halicka, HD; Li, CJ; Vivo, C | 1 |
Cervantes-Gomez, F; Gandhi, V; Nimmanapalli, R | 1 |
2 other study(ies) available for dactinomycin and tanespimycin
Article | Year |
---|---|
Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection.
Topics: Amino Acid Chloromethyl Ketones; Antibiotics, Antineoplastic; Apoptosis; Benzoquinones; Caspase 9; Caspase Inhibitors; Cell Cycle; Cell Line, Tumor; Cytoprotection; Dactinomycin; Doxorubicin; Enzyme Activation; Flavonoids; HSP70 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Paclitaxel; Piperidines; Protein Biosynthesis; RNA, Small Interfering; Transcriptional Activation | 2006 |
Transcription inhibition of heat shock proteins: a strategy for combination of 17-allylamino-17-demethoxygeldanamycin and actinomycin d.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Cell Line, Tumor; Dactinomycin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Heat Shock Transcription Factors; Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Multiple Myeloma; RNA, Messenger; RNA, Neoplasm; Transcription Factors; Transcription, Genetic | 2009 |